Despite significant progress in healthcare, unmet need remains vast. How we live, eat and move are defining our health.
That’s why we work with partners to help prevent diseases and expand access to treatment, with the target of reaching 100 million children and underserved people by 2030, while reducing our environmental impact.
Healthy choices are not always easy choices. We work with cities, communities and partners such as UNICEF to help make healthier living possible for more children.
Too many people still face barriers to the treatment they need. Through Access for Better Health, we work with partners to build evidence, implement solutions and strengthen health systems to help more people access the treatment and care they need.
Human health depends on a healthy planet. As we grow to serve more people, we take action through our Circular for Zero programme to reduce our environmental impact by cutting emissions, rethinking chemistry, protecting nature and designing for circularity.
Our ambition is to generate scaled reach and breakthrough evidence in prevention and equitable access that delivers better health outcomes and value to society at scale.
Our target is to reach 100 million children and underserved people by 2030 through prevention efforts and access to treatment. The target is based on the number of children and underserved people we believe we can reach through our prevention and access initiatives, social responsibility programmes and partnerships by 2030.
Together with UNICEF, we aim to reach more than 80 million children by 2030 by helping create healthier environments and strengthening the policies and systems that support better health.
We aim to reach more than 10 million underserved people with Novo products by 2030, expanding access to care and treatment for lasting health.
We partner to scale our impact, for example through programmes such as Cities for Better Health and the Childhood Obesity Prevention Initiative, and partnerships including the WHO Foundation and Novartis Foundation.
As we grow to serve more people, the need for materials, energy and water increase. To deliver sustainable growth we remain committed to our four environmental priorities:
Our ambition is to decouple emissions from growth across our value chain.
Our target is to reach net zero emissions across the value chain by 2045. This includes a 75% reduction in emissions from our own operations and a 33% reduction across our value chain by 2033, with 2024 as the baseline year.
Our ambition is to mitigate impacts and dependencies on natural resources to halt the loss of nature by 2033 and contribute to global nature positive outcomes by 2045.
Our targets include 100% glucose from regenerative agriculture by 2033, deforestation-free supply chain by 2030, and two water restoration projects by 2030.
We focus on reducing the use of toxic chemicals and minimise pharmaceuticals in the environment
We aim to reduce environmental impacts through integration of circularity in product and process design.
Our target is: all new products assessed by Circular Product Design Framework and Life Cycle Assessments covering top 30-selling products by end 2027.
